Summary: Lysosomes are the recycling centers of the cell where organelles and proteins are degraded during autophagy and macropinocytosis; they also serve as signaling hubs that control the activity of mTORC1. In this issue, Rebecca and colleagues report the development of a new type of lysosomal inhibitor for cancer therapy that can inhibit multiple lysosomal activities that are needed for tumor cell survival and growth. Cancer Discov; 7(11); 1218–20. ©2017 AACR.
See related article by Rebecca et al., p. 1266.
from Cancer via ola Kala on Inoreader http://ift.tt/2iRzT1g
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου